Symmetry Peak Management LLC Purchases 3,182 Shares of Intermolecular, Inc. (IMI)

Symmetry Peak Management LLC boosted its stake in shares of Intermolecular, Inc. (NASDAQ:IMI) by 0.3% during the first quarter, Holdings Channel reports. The fund owned 1,023,323 shares of the semiconductor company’s stock after buying an additional 3,182 shares during the period. Symmetry Peak Management LLC’s holdings in Intermolecular were worth $952,000 at the end of the most recent quarter.

Separately, Renaissance Technologies LLC boosted its position in shares of Intermolecular by 0.6% in the first quarter. Renaissance Technologies LLC now owns 831,499 shares of the semiconductor company’s stock valued at $773,000 after buying an additional 4,633 shares during the period. 38.93% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Intermolecular (NASDAQ:IMI)

Shares of Intermolecular, Inc. (IMI) traded up 9.09% during trading on Friday, hitting $0.96. The company’s stock had a trading volume of 2,627 shares. The stock’s market cap is $47.58 million. The company has a 50-day moving average price of $0.87 and a 200-day moving average price of $0.97. Intermolecular, Inc. has a one year low of $0.78 and a one year high of $1.70.

COPYRIGHT VIOLATION WARNING: This article was originally reported by WKRB News and is the sole property of of WKRB News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at

Separately, Needham & Company LLC reissued a “hold” rating on shares of Intermolecular in a report on Thursday, February 16th.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Want to see what other hedge funds are holding IMI? Visit to get the latest 13F filings and insider trades for Intermolecular, Inc. (NASDAQ:IMI).

This story was originally published by WKRB News ( and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with's FREE daily email newsletter.


Leave a Reply

© 2006-2017 WKRB News.